If you or a loved one have developed a form of pancreatitis while taking Byetta, you should contact an Injury Help Network attorney immediately. You may be entitled to compensation for your injuries and/or loss and our lawyers can help.
About this Byetta FDA Video
IMPORTANT INFORMATION: The video below is outdated (October 2007). The U.S. Food & Drug Administration has released new information linking Byetta to numerous deaths and hospitalizations. You can read more about the new FDA warnings by clicking the link below.
FDA is alerting healthcare professionals that Byetta (exenatide) may be associated with acute pancreatitis in some patients. Byetta is administered subcutaneously to treat type 2 diabetes.
FDA has reviewed 30 reports of acute pancreatitis in patients taking Byetta. Twenty-one were hospitalized, five of them with serious complications. Twenty-two of the patients improved after discontinuing the drug.
Practitioners should be alert to the signs and symptoms of pancreatitis in patients taking Byetta. If pancreatitis is suspected, discontinue the drug. If the diagnosis is confirmed, do not restart Byetta unless an alternative cause for the pancreatitis is identified.
Patients taking Byetta should be cautioned to promptly seek medical care if they experience symptoms of pancreatitis, such as persistent and severe abdominal pain, possibly accompanied by vomiting.
The manufacturer of Byetta, Amylin Pharmaceuticals, has agreed to include information about pancreatitis in the Precautions section of the drug’s labeling.
Do I Have a Byetta Lawsuit?
If you or a loved one have developed a form of pancreatitis while taking Byetta, you should contact an Injury Help Network attorney immediately. You may be entitled to compensation for your injuries and/or loss and our lawyers can help.
On August 18, 2008 the U.S. Food & Drug Administration (FDA) issued a public health warning concerning the popular type 2 diabetes drug Byetta. This most recent FDA warning is in addition to the October 2007 warning issued regarding over 30 cases of acute pancreatitis.
If you or a loved one have developed a form of pancreatitis while taking Byetta, you should contact an Injury Help Network attorney immediately. You may be entitled to compensation for your injuries and/or loss and our lawyers can help.
Update 8/18/2008: Since issuing Information for Healthcare Professionals in October 2007, FDA has received reports of 6 cases of hemorrhagic or necrotizing pancreatitis in patients taking Byetta. Byetta is a medicine given by subcutaneous injection to help treat adults with type 2 diabetes. Of the 6 cases of hemorrhagic or necrotizing pancreatitis, all patients required hospitalization, two patients died and four patients were recovering at time of reporting. Byetta was discontinued in all 6 cases.
Byetta and other potentially suspect drugs should be promptly discontinued if pancreatitis is suspected. There are no signs or symptoms that distinguish acute hemorrhagic or necrotizing pancreatitis associated with Byetta from the less severe form of pancreatitis. If pancreatitis is confirmed, initiate appropriate treatment and carefully monitor the patient until recovery. Byetta should not be restarted. Consider antidiabetic therapies other than Byetta in patients with a history of pancreatitis.
FDA is working with the maker of Byetta, Amylin Pharmaceuticals, Inc., to add stronger and more prominent warnings in the product label about the risk of acute hemorrhagic or necrotizing pancreatitis.
Do I Have a Byetta Lawsuit?
If you or a loved one have developed a form of pancreatitis while taking Byetta, you should contact an Injury Help Network attorney immediately. You may be entitled to compensation for your injuries and/or loss and our lawyers can help.
San Diego, CA (8/20/08) - Injury Help Network attorneys Thomas M. Moore and Michael E. Schmidt are first to file lawsuit against Amylin Pharmaceuticals, Inc., and the drug’s co-marketer, Eli Lilly and Company.
AMYLIN PHARMACEUTICALS DIABETES DRUG BYETTA® THE FOCUS OF CALIFORNIA LAWSUIT
Moore Labriola LLP and The Schmidt Firm, LLP Represent Virgina Man Who Developed Pancreatitis; FDA Seeks More Stringent Warnings
(San Diego, CA) — A Virginia man yesterday filed what is believed to be the first personal injury lawsuit stemming from injuries associated with the use of Byetta®, an injectable medication for diabetes. Victor Deleon alleges in a lawsuit filed in San Diego Superior Court (Case No. 37-2008-00090003-CU-PL-CTL) that the manufacturer of the drug, San Diego-based Amylin Pharmaceuticals, Inc., and the drug’s co-marketer, Eli Lilly and Company, failed to adequately test and monitor the side effects of Byetta® and didn’t warn doctors or patients of the risk of developing pancreatitis. Deleon was hospitalized in December of 2007 after developing the
condition, which causes inflammation of the pancreas and can lead to bleeding and death.
Deleon’s lawsuit comes two days after the Food and Drug Administration announced that it has received six reports of hemorrhagic or necrotizing pancreatitis in patients taking Byetta® since October of 2007. Two of the six patients died. In a press release, the FDA said it is “working with the maker of Byetta®” to add “stronger and more prominent warnings” to the product’s label.
Deleon’s lawsuit alleges that Amylin “failed to adequately warn prescribing physicians of the risk of pancreatitis, of measures needed to properly assess the appropriateness of prescribing the drug to certain categories of patients, and of measures doctors and patients could and should take to minimize the risk.”
In the fall of 2007, Amylin agreed to add information about pancreatitis to the “precautions” section of the Byetta® label after the FDA reported 30 post-marketing reports of acute pancreatitis associated with the drug. “It is pretty obvious that the label change in 2007 was not adequate,” said Thomas M. Moore of Moore Labriola LLP in Newport Beach who jointly represents Mr. Deleon with Michael Schmidt of The Schmidt Firm, LLP in Dallas “We believe that Amylin possessed data prior to the 2007 label revision that justified a stronger and more prominent warning than the precaution language that Amylin ultimately negotiated with FDA,” Moore added.
If you or a loved one have developed a form of pancreatitis while taking Byetta, you should contact an Injury Help Network attorney immediately. You may be entitled to compensation for your injuries and/or loss and our lawyers can help.
If you or someone you know has been injured, we can help. No matter what type of case you have, you may contact us directly through the contact form below or by calling toll free 24 hrs/day (866) 879-3040.
Secure 128-bit SSL Encrypted Email Communication Click Here
I'd like to first take this opportunity to thank you for visiting our website.
We developed the Injury Help Network in order to provide injured individuals and families with up-to-date legal information, news, analysis, and commentary regarding their potential case.
At the heart of this website is the Individual Attorney Blogs where our group of "invitation only" attorneys have decided to create a home for their thoughts, comments and published information regarding cases their law firms are currently investigating, accepting and/or handling.
By contacting us through this website, I assure you that your case will be reviewed by a group of attorneys recognized as some of America’s most dynamic, accomplished and skilled trial lawyers.
There is no cost associated with submitting your information to us, as we offer a Free Confidential Case Evaluation.
Please browse our website and Individual Attorney Blogs carefully to learn more about our work and the specific types of cases we handle.
We want you to be sure that our group of attorneys has the experience and resources you need while also providing you with valuable information regarding your potential case.
Thanks again for visiting our website. We look forward to helping you.
Michael E. Schmidt Managing Partner
Schmidt & Clark | A National Law Firm
Can't Find What You're Looking For?
Please use the search box below to search the entire Injury Help Network article index.
Secure 128-bit SSL Encrypted Email Communication
